FdaApplication
NDA 204516
Identifiers
- fda_app_no: NDA204516
Properties
| Property | Value |
|---|---|
| applicant_name | LEGACY PHARMA INC SEZC |
| application_type | NDA |
| approval_date | 2013-06-28 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BRISDELLE | PAROXETINE MESYLATE | EQ 7.5MG BASE | CAPSULE;ORAL |
1 product